English
+38 044 223 28 95
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Request Info

News and Articles on Arterial Hypertension

Clinical Trial Shows Stem Cells Ability to Regulate Blood Pressure in Patients with Rare Lung Disease

12 July 2015

The first ever clinical trial of a genetically-enhanced stem cell treatment for pulmonary arterial hypertension (PAH) has shown promising results, Canadian researchers report.

All news

Arterial Hypertension

Stem cell therapy has pronounced positive effect in treatment of arterial hypertension (elevated blood pressure). In particular, at Cell Therapy Center EmCell patients with primary arterial hypertension grade II with frequent arterial crises receive transplantation of fetal stem cells of ectodermal and mesenchymal origin.

Prior to transplantation, continuous hypotensive therapy regimen is selected; that allowed for preventing hypertensive crises, and diastolic pressure stabilizes at the level no higher than 90 mm Hg.

In 3–5 months after transplantation of fetal stem cells, all patients demonstrate stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%. Over time, 85% of patients lose the need for hypotensive therapy.

All patients note positive effect of treatment that is about disappearance of headache, stabiliziation and normalization of blood pressure and sleep, improved mental ability and sexual potency (both in men and women), return of vivacity – signs of rejuvenation.
 

Fetal Stem Cells in Post-Stroke Cognitive Deficit. Poster session.

Request additional information
Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.

Our stories

Our patents